GSK and Zhifei Biological recently formed an exclusive partnership to jointly promote GSK's shingles vaccine, Shingrix, to healthcare professionals and vaccination centers. MediLink Therapeutics announced that it has entered into an agreement with BioNTech SE on the development of a next-generation antibody-drug conjugate candidate (ADC) against Human Epidermal Growth Factor Receptor 3 (HER3).